Re: The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men

Samir S. Taneja

    Research output: Contribution to journalEditorialpeer-review

    Original languageEnglish (US)
    Number of pages1
    JournalThe Journal of urology
    Volume193
    Issue number1
    DOIs
    StatePublished - Jan 1 2015

    ASJC Scopus subject areas

    • Urology

    Cite this